ArticleScientific reports2025
AI-CMCA: a deep learning-based segmentation framework for capillary microfluidic chip analysis.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Machine Learning-Driven Capillary Microfluidic Design Automation for Programmable Gradient Generation and Antimicrobial Testing.Small (Weinheim an der Bergstrasse, Germany) · 2026Article
- AI and Microfluidics: Unlocking Cellular Motility for Bioengineering.Bioengineering (Basel, Switzerland) · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
Capillary microfluidic chips (CMCs) enable passive liquid transport via surface tension and wettability gradients, making them central to point-of-care diagnostics and biomedical sensing. However, accurate analysis of capillary-driven flow experiments remains constrained by the labour-intensive, time-consuming, and inconsistent nature of manual fluid path tracking. Here, we present AI-CMCA, an artificial intelligence framework designed for capillary microfluidic chip analysis, which automates fluid path detection and tracking using deep learning-based segmentation. AI-CMCA combines transfer learning-based feature initialization, encoder-decoder-based semantic segmentation to recognize fluid in each frame, and sequential frame analysis to track then quantify fluid progression. Among the five tested architectures, including U-Net, PAN, FPN, PSP-Net, and DeepLabV3+, the U-Net model with MobileNetV2 achieved the highest performance, with a validation IoU of 99.24% and an F1-score of 99.56%. Its lightweight design makes it well suited for smartphone or edge deployment. AI-CMCA demonstrated a strong correlation with manually extracted data while offering superior robustness and consistency in fluid path analysis. AI-CMCA performed fluid path analysis up to 100 times faster and over 10 times more consistently than manual tracking, reducing analysis time from days to minutes while maintaining high precision and reproducibility across diverse CMC architectures. By eliminating the need for manual annotation, AI-CMCA significantly enhances efficiency, precision, and automation in microfluidic research.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.